Trials / Recruiting
RecruitingNCT04804202
Virtual Cycling Environments for Persons With Parkinson Disease
Virtual Cycling Environments (VCYCLE) Increases Exercise Intensity of Persons With Parkinson Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study asks three questions about Persons with Parkinson Disease that use a bicycle for exercise. 1. Does the use of virtual reality increase the intensity and and enjoyment of the experience compared to bicycling without virtual reality? 2. Does the way in which the bicycling (interval compared to continous) is performed affect the experience? 3. How does the way the virtual reality is delivered (with goggles or projected on a screen) affect the experience?
Detailed description
Participants attend two sessions. They complete movement assessments and questionnaires about physical activity. During the first session they bicycle in a semi-immersive (projected on a screen) and an immersive (with googles) virtual environment. After each bout they completed a questionnaire about the experience. In the second session they bicycle four times with and without a virtual environment using both a continous and interval mode. Their oxygen consumption is measured during cycling. They complete questionnaires after each exercise bout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bicycling with and without virtual reality | In one session: Exercise intensity and enjoyment are measured while participants bicycle in a virtual compared to non-virtual environment. Cycling takes places in two modes continous and interval. In a second session exercise intensity and enjoyment are compared during bicycling with virtual reality presented in two different ways. |
Timeline
- Start date
- 2021-02-08
- Primary completion
- 2026-08-01
- Completion
- 2026-12-30
- First posted
- 2021-03-18
- Last updated
- 2025-05-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04804202. Inclusion in this directory is not an endorsement.